Abstract
Objectives
Cardiovascular diseases (CVD) are a major cause of death and a public health threat. To report the burden of CVD in Mexico at a national and subnational scale from 1990 to 2017 as well as risk factors driving these changes.
Methods
Following the 2017 global burden of disease study, mortality, disability-adjusted life-years (DALYs), and risk factors of CVD were examined according to 10 subcategories.
Results
The CVD burden of disease decreased between 1990 and 2017 in Mexico as a whole and in all states, with the higher decrease located in the north and central regions. Ischemic heart disease accounted for almost two-thirds of the total number of deaths from CVD and caused the highest DALY rate. The leading CVD risk factors were high systolic blood pressure, dietary risks, high LDL cholesterol, high BMI, and high fasting plasma glucose level.
Conclusions
These results allow the establishment of priorities, policy development, and implementation to decrease the CVD burden and can provide a benchmark for states to focus on key risk factors, improve the quality of health care, and reduce health care costs.
Similar content being viewed by others
References
2017-GBoDS (2018) The GBD 2017 ICD code mappings Institute for Health Metrics and Evaluation. http://ghdx.healthdata.org/record/ihme-data/gbd-2017-cause-icd-code-mappings. Accessed 9 Nov 2019
Acosta-Cazares B, Escobedo J (2010) High burden of cardiovascular disease risk factors in Mexico: An epidemic of ischemic heart disease that may be on its way? Am Heart J 160:230–236. https://doi.org/10.1016/j.ahj.2010.05.016
Arroyo-Quiroz C, Barrientos-Gutierrez T, Oflaherty M et al (2020) Coronary heart disease mortality is decreasing in Argentina, and Colombia, but keeps increasing in Mexico: a time trend study. BMC Public Health 20:162. https://doi.org/10.1186/s12889-020-8297-5
Basto-Abreu A, Barrientos-Gutierrez T, Vidana-Perez D et al (2019) Cost-effectiveness of the sugar-sweetened beverage excise tax in Mexico. Health Aff (Millwood) 38:1824–1831. https://doi.org/10.1377/hlthaff.2018.05469
Beltran-Sanchez H, Crimmins EM (2013) Biological risk in the Mexican population at the turn of the 21st century. J Cross Cult Gerontol 28:299–316. https://doi.org/10.1007/s10823-013-9199-0
Chow CK, Teo KK, Rangarajan S et al (2013) Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310:959–968. https://doi.org/10.1001/jama.2013.184182
Collaborators GBDCOD (2018a) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet 392:1736–1788. https://doi.org/10.1016/s0140-6736(18)32203-7
Collaborators GBDEMRCD (2018b) Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990–2015: findings from the global burden of disease 2015 study. Int J Public Health 63:137–149. https://doi.org/10.1007/s00038-017-1012-3
Collaborators GBDM (2018c) Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the global burden of disease study 2017. Lancet 392:1684–1735. https://doi.org/10.1016/s0140-6736(18)31891-9
Collaborators GBDRF (2018d) Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 392:1923–1994. https://doi.org/10.1016/s0140-6736(18)32225-6
CONAPO (2019) The 2015 state and municipality marginality-index. National Population Council. https://www.gob.mx/conapo/documentos/indice-de-marginacion-por-entidad-federativa-y-municipio-2015. Accessed 26 Mar 2020
DALYs GBD, Collaborators H (2018) Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 392:1859–1922. https://doi.org/10.1016/S0140-6736(18)32335-3
Disease GBD, Injury I, Prevalence C (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 392:1789–1858. https://doi.org/10.1016/S0140-6736(18)32279-7
Foreman KJ, Marquez N, Dolgert A et al (2018) Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392:2052–2090. https://doi.org/10.1016/s0140-6736(18)31694-5
Gálvez A (2018) Eating NAFTA: trade, food policies, and the destruction of Mexico. University of California Press, Oakland
GBD-2017 GBoDS (2018a) The GBD 2017 socio-demographic index. Institute for Health Metrics and Evaluation (IHME). http://ghdx.healthdata.org/record/ihme-data/gbd-2017-socio-demographic-index-sdi-1950%E2%80%932017. Accessed 22 Mar 2020
GBD-2017 GBoDS (2018b) Global burden of disease study 2017 (GBD 2017) results. Institute for Health Metrics and Evaluation (IHME). https://vizhub.healthdata.org/gbd-compare/. Accessed 11 Nov 2019
Gomez-Dantes O, Sesma S, Becerril VM et al (2011) The health system of Mexico. Salud Publica Mex 53(Suppl 2):s220–s232
Gomez-Dantes H, Fullman N, Lamadrid-Figueroa H et al (2016) Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet 388:2386–2402. https://doi.org/10.1016/S0140-6736(16)31773-1
Gonzalez-Villalpando C, Davila-Cervantes CA, Zamora-Macorra M et al (2014) Incidence of type 2 diabetes in Mexico: results of the Mexico City diabetes study after 18 years of follow-up. Salud Publica Mex 56:11–17. https://doi.org/10.21149/spm.v56i1.7318
Gulland A (2016) Global life expectancy increases by five years. BMJ 353:i2883. https://doi.org/10.1136/bmj.i2883
Gupta R, Mohan I, Narula J (2016) Trends in coronary heart disease epidemiology in India. Ann Glob Health 82:307–315. https://doi.org/10.1016/j.aogh.2016.04.002
Gutierrez JP, Garcia-Saiso S, Espinosa-de la Pena R et al (2016) Inequalities on indicators of chronic conditions among adults in Mexico: analysis of three health surveys. Salud Publica Mex 58:666–675. https://doi.org/10.21149/spm.v58i6.7923
Health NIoP (2019) Encuesta Nacional de Salud y Nutrición 2018. Presentacion de Restultados, 1st edn. National Institute of Public Health, Mexico
Jagannathan R, Patel SA, Ali MK et al (2019) Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors. Curr Diabetes Rep 19:44. https://doi.org/10.1007/s11892-019-1161-2
Joseph P, Leong D, McKee M et al (2017) Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res 121:677–694. https://doi.org/10.1161/circresaha.117.308903
Liu S, Li Y, Zeng X et al (2019) Burden of cardiovascular diseases in China, 1990–2016: findings from the global burden of disease study 2016. JAMA Cardiol 4:342–352. https://doi.org/10.1001/jamacardio.2019.0295
Mensah GA, Roth GA, Sampson UK et al (2015) Mortality from cardiovascular diseases in sub-Saharan Africa, 1990–2013: a systematic analysis of data from the global burden of disease study 2013. Cardiovasc J Afr 26:S6–10. https://doi.org/10.5830/CVJA-2015-036
Moran AE, Forouzanfar MH, Roth GA et al (2014) The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study. Circulation 129:1493–1501. https://doi.org/10.1161/circulationaha.113.004046
Murray CJL, Lopez AD (2017) Measuring global health: motivation and evolution of the global burden of disease study. Lancet 390:1460–1464. https://doi.org/10.1016/S0140-6736(17)32367-X
Nascimento BR, Brant LCC, Oliveira GMM et al (2018) Cardiovascular disease epidemiology in portuguese-speaking countries: data from the global burden of disease, 1990 to2016. Arq Bras Cardiol 110:500–511. https://doi.org/10.5935/abc.20180098
Nations U (2019) Sustainable development goal 3: ensure healthy lives and promote well-being for all at all ages. United Nations. https://sustainabledevelopment.un.org/sdg3. Accessed 11 Nov 2019
Pagan E, Chatenoud L, Rodriguez T et al (2017) Comparison of trends in mortality from coronary heart and cerebrovascular diseases in North and South America: 1980 to 2013. Am J Cardiol 119:862–871. https://doi.org/10.1016/j.amjcard.2016.11.040
Parra-Rodriguez L, Gonzalez-Meljem JM, Gomez-Dantes H et al (2019) The burden of disease in Mexican older adults: premature mortality challenging a limited-resource health system. J Aging Health. https://doi.org/10.1177/0898264319836514
Prabhakaran D, Jeemon P, Sharma M et al (2018) The changing patterns of cardiovascular diseases and their risk factors in the states of India: the global burden of disease study 1990–2016. Lancet Glob Health 6:e1339–e1351. https://doi.org/10.1016/s2214-109x(18)30407-8
Reynales-Shigematsu LM (2016) Tobacco and cancer: epidemiology and new perspectives of prevention and monitoring in Mexico. Salud Publica Mex 58:251–260. https://doi.org/10.21149/spm.v58i2.7794
Rosas-Peralta M, Arizmendi-Uribe E, Borrayo-Sanchez G (2017) What do adults die in Mexico? Impact on the economic and social development of the nation. The global burden of cardiovascular disease. Rev Med Inst Mex Seguro Soc 55(1):98–103
Roth GA, Johnson C, Abajobir A et al (2017) Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 70:1–25. https://doi.org/10.1016/j.jacc.2017.04.052
Roth GA, Johnson CO, Abate KH et al. (2018) The Burden of Cardiovascular Diseases Among US States, 1990-2016 JAMA Cardiol 3:375-389 https://doi.org/10.1001/jamacardio.2018.0385
Villalpando S, Shamah-Levy T, Rojas R et al (2010) Trends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993–2006. Salud Publica Mex 52(Suppl 1):S72–S79. https://doi.org/10.1590/s0036-36342010000700011
Funding
The study received no funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Dávila-Cervantes, C.A. Cardiovascular disease in Mexico 1990–2017: secondary data analysis from the global burden of disease study. Int J Public Health 65, 661–671 (2020). https://doi.org/10.1007/s00038-020-01377-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00038-020-01377-4